Morning Briefing
Summaries of health policy coverage from major news organizations
Oklahoma's Star Witness In Opioid Trial Says J&J 'Did Everything' To Push Painkillers Even When Dangers Were Long Established
Bloomberg: Johnson & Johnson Fueled Opioid Crisis, Trial Witness Testifies
Oklahoma’s star witness told a state judge that Johnson & Johnson pressed doctors to prescribe its painkillers even as the potentially fatal addictive threat posed by the drugs became clear more than a decade ago. The judge, Thad Balkman, is presiding over the non-jury case and will make the final decision in the first trial where a state seeks to hold a drug maker responsible for contributing to the U.S. opioid epidemic. Oklahoma is seeking $13 billion in damages from J&J. (Harris and Feeley, 6/11)
The Associated Press: Oklahoma Judge Wants More Answers On $85M Opioid Settlement
An Oklahoma judge is declining to approve the state's proposed $85 million settlement with an opioid maker until he's assured it complies with a new law targeting such deals. The attorney general's office says Cleveland County Judge Thad Balkman on Monday ordered attorneys for both the state and Israeli-owned Teva Pharmaceuticals to file additional paperwork before he approves the settlement. (6/10)
The Washington Post: Maryland Opioid Epidemic: Overdose Deaths Down For First Time In 10 Years
Fewer people died of heroin and fentanyl in Maryland in the first quarter of 2019 than during the same period the previous year, preliminary data shows, marking the state’s first decline in fatal opioid overdoses in a decade. Though the data represents a 14 percent decline, or 85 fewer deaths, Maryland public health officials were quick to point out that the opioid epidemic continues at a historic pace, killing more than 500 people in the first three months of this year. (Cox, 6/11)
North Carolina Health News: As The Opioid Death Count Climbs, Will North Carolina Try What’s Worked Elsewhere?
While syringe exchanges were legalized in 2016, there has been a ban on any state money going to fund them. That might change. Sen. Jim Davis (R-Franklin), who has led the state on opioid legislation the last few years, recently introduced the Opioid Epidemic Response Act, which would lift the ban on state funds going to needle exchanges. It would also decriminalize drug testing equipment, which Davis said is vital as more controlled substances are laced with fentanyl, a drug that can be 100 times more potent than morphine. (Knopf, 6/12)
California Healthline: Drug Users Armed With Naloxone Double As Medics On Streets Of San Francisco
The man was out of his wheelchair and lay flat on his back just off San Francisco’s Market Street, waiting for the hypodermic needle to pierce his skin and that familiar euphoric feeling to wash over him. The old-timer, who appeared to be in his 60s, could not find a viable vein, so a 38-year-old man named Daniel Hogan helped him. Hogan, a longtime drug user originally from St. Louis, leaned over the older man, eyeing his neck as he readied a syringe loaded with the powerful synthetic opioid fentanyl. (Rinker, 6/11)
The CT Mirror: Officials Gather In Hartford To Address Outbreak Of Opioid Deaths
As state lawmakers were unanimously passing a comprehensive bill to address Connecticut’s opioid crisis last week, Hartford was experiencing an unprecedented outbreak of opioid-related deaths, causing alarm among advocates, lawmakers and city officials. Monday, those alarmed officials gathered at the behest of Sen. Richard Blumenthal at the Asylum Hill Congregational Church to discuss measures to effectively address the crisis. (Moore and Radelat, 6/10)
WBUR: The Van Vs. An Opioid Addiction: Taking Treatment To The Streets
The Care Zone van, funded by the Kraft Center for Community Health at Massachusetts General Hospital, is one of a half dozen or so projects across the country testing models for this theory: If the U.S. wants to end the opioid epidemic, it must make treatment as available as drugs. (Bebinger, 6/12)
